Literature DB >> 16374000

Normobaric hyperoxia - a promising approach to expand the time window for acute stroke treatment.

Nils Henninger1, Marc Fisher.   

Abstract

Entities:  

Year:  2005        PMID： 16374000     DOI： 10.1159/000090446

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN： 1015-9770            Impact factor:   2.762


× No keyword cloud information.
  14 in total

Review 1.  Non-pharmaceutical therapies for stroke: mechanisms and clinical implications.

Authors:  Fan Chen; Zhifeng Qi; Yuming Luo; Taylor Hinchliffe; Guanghong Ding; Ying Xia; Xunming Ji
Journal:  Prog Neurobiol       Date:  2014-01-07       Impact factor: 11.685

2.  Reduction of zinc accumulation in mitochondria contributes to decreased cerebral ischemic injury by normobaric hyperoxia treatment in an experimental stroke model.

Authors:  Wen Dong; Zhifeng Qi; Jia Liang; Wenjuan Shi; Yongmei Zhao; Yumin Luo; Xunming Ji; Ke Jian Liu
Journal:  Exp Neurol       Date:  2015-04-17       Impact factor: 5.330

3.  Normobaric Hyperoxia Extends Neuro- and Vaso-Protection of N-Acetylcysteine in Transient Focal Ischemia.

Authors:  Yushan Liu; Wen-Cao Liu; Yanyun Sun; Xianzhi Shen; Xiaona Wang; Hui Shu; Rong Pan; Chun-Feng Liu; Wenlan Liu; Ke Jian Liu; Xinchun Jin
Journal:  Mol Neurobiol       Date:  2016-05-13       Impact factor: 5.590

4.  Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.

Authors:  Jia Liang; Zhifeng Qi; Wenlan Liu; Peng Wang; Wenjuan Shi; Wen Dong; Xunming Ji; Yumin Luo; Ke Jian Liu
Journal:  Stroke       Date:  2015-03-24       Impact factor: 7.914

5.  Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia.

Authors:  Wenlan Liu; Jill Hendren; Xu-Jun Qin; Jiangang Shen; Ke Jian Liu
Journal:  J Neurochem       Date:  2009-02       Impact factor: 5.372

6.  Normobaric hyperoxia combined with minocycline provides greater neuroprotection than either alone in transient focal cerebral ischemia.

Authors:  Xinchun Jin; Jie Liu; Ke J Liu; Gary A Rosenberg; Yi Yang; Wenlan Liu
Journal:  Exp Neurol       Date:  2012-11-26       Impact factor: 5.330

7.  Normobaric hyperoxia-based neuroprotective therapies in ischemic stroke.

Authors:  Zhifeng Qi; Wenlan Liu; Yumin Luo; Xunming Ji; Ke Jian Liu
Journal:  Med Gas Res       Date:  2013-01-09

8.  Normobaric hyperoxia protects the blood brain barrier through inhibiting Nox2 containing NADPH oxidase in ischemic stroke.

Authors:  Wenlan Liu; Qingquan Chen; Jie Liu; Ke Jian Liu
Journal:  Med Gas Res       Date:  2011-09-06

9.  MCP-induced protein 1 mediates the minocycline-induced neuroprotection against cerebral ischemia/reperfusion injury in vitro and in vivo.

Authors:  Zhuqing Jin; Jian Liang; Jing Wang; Pappachan E Kolattukudy
Journal:  J Neuroinflammation       Date:  2015-02-27       Impact factor: 8.322

10.  Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke.

Authors:  Norio Fujiwara; Yoshihiro Murata; Ken Arai; Yasuhiro Egi; Jie Lu; Ona Wu; Aneesh B Singhal; Eng H Lo
Journal:  BMC Neurosci       Date:  2009-07-15       Impact factor: 3.288
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.